Treatment of Herpes Labialis by Photodynamic Therapy

Status Completed

Clinical Trial Summary

Lesions of herpes labialis are caused by the herpes simplex virus type 1 (HSV-1) and cause pain and aesthetic compromise. It is characterized by the formation of small vesicles that coalesce and rupture forming extremely painful ulcers, that evolve to crusts, dry desquamations until their complete remission. Currently, the treatment of these lesions is done with acyclovir. Although it diminishes the symptomatology, it causes viral resistance and does not prevent the recurrence of the lesions. It is known that photodynamic therapy (PDT) has numerous advantages, among them: the reduction of the time of remission, and does not cause resistance. A total of 30 patients with herpes labialis in the prodromal stage of vesicles, ulcers, and crusts will be selected to participate in the study and randomized into two groups: G1 control and G2 experimental. After signing informed consent, patients in group G1 will undergo the standard gold treatment for cold sores with acyclovir and simulated PDT treatment. Patients in the experimental G2 group will be treated simulating the gold standard treatment of herpes labialis (placebo) and PDT.

Clinical Trial Description

Lesions of herpes labialis are caused by the herpes simplex virus type 1 (HSV-1) and cause pain and aesthetic compromise. It is characterized by the formation of small vesicles that coalesce and rupture forming extremely painful ulcers, that evolve to crusts, dry desquamations until their complete remission. Currently, the treatment of these lesions is done with acyclovir. Although it diminishes the symptomatology, it causes viral resistance and does not prevent the recurrence of the lesions. It is known that photodynamic therapy (PDT) has numerous advantages, among them: the reduction of the time of remission, and does not cause resistance. Materials and methods: A total of 30 patients with herpes labialis in the prodromal stage of vesicles, ulcers, and crusts will be selected to participate in the study and randomized into two groups: G1 control and G2 experimental. After signing TCLE and TA, patients in group G1 will undergo the standard gold treatment for cold sores with acyclovir and simulated PDT treatment. Patients in the experimental G2 group will be treated simulating the gold standard treatment of herpes labialis (placebo) and PDT. In all patients will be collected saliva samples for analysis of cytokines, and will be performed exfoliative cytology in the lesions. The pain will be assessed through a pain scale and a questionnaire of quality of life-related to oral health (Ohip- 14) will be given to them. Patients will continue to be followed up after 7 days, 1 month, 3 months, 6 months and 1 year and, if there is a recurrence of the lesion, they will contact the researchers. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04037475
Study type	Interventional
Source	University of Nove de Julho
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2020
Completion date	October 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06052033` - Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection	N/A
Recruiting	`NCT05031923` - Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy	N/A
Completed	`NCT04037709` - Photodynamic Therapy in Patients With Gingivitis	N/A
Recruiting	`NCT05043935` - The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Aggressive Periodontitis	N/A
Not yet recruiting	`NCT06437288` - Hematoporphyrin Photodynamic Therapy for Esophageal Cancer	Phase 2
Completed	`NCT01756313` - Optimizing Uptake of Methylaminolevulinat With Fractional Ablative Laser Technique	Phase 4
Withdrawn	`NCT03960125` - Photodynamic Therapy and Microvesicles	Early Phase 1
Recruiting	`NCT01349361` - Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight	Phase 2
Not yet recruiting	`NCT06468540` - Combination of Micropulse Laser With or Without Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Recruiting	`NCT05688904` - The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy	Phase 1
Recruiting	`NCT06445699` - Photodynamic Therapy With Hydrogel Dressing for Chronic Wounds	N/A
Recruiting	`NCT04689243` - Low Concentration ALA-PDT in Treatment of Skin Ulcer	N/A
Recruiting	`NCT06311890` - Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne	Phase 2
Enrolling by invitation	`NCT05820750` - Clinical and Radiographic Evaluation of Photodynamic Therapy for Root Canal Treatment of Primary Molars	N/A
Enrolling by invitation	`NCT04223570` - Portable Measurement of Protoporphyrin IX in the Skin
Completed	`NCT03643744` - Photodynamic Therapy-Induced Immune Modulation: Part III	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Treatment of Herpes Labialis by Photodynamic Therapy — Herpes

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms